Your hands can offer early clues to liver problems. Changes like red palms, itchy skin, brittle nails, and trembling fingers ...

Your hands can offer early warnings of liver trouble. Look for red palms, changes in nails like brittleness or white tips, ...

Building on earlier studies showing its benefits for type 2 diabetes, a new study has revealed the experimental drug IC7Fc ...

With the rise in Lyme disease cases in the US, it is increasingly important to stay current with the latest treatment ...

Victor Sung, M.D., director of the Division of Movement Disorders in the University of Alabama at Birmingham Department of Neurology and director of the UAB Huntington’s Disease Clinic, reacted to the ...

A new treatment that proves to slow the progression of Huntington’s disease (HD) marks a breakthrough for a condition that has long been considered untreatable. Huntington’s is a rare, inherited ...

The world’s deadliest infectious disease urgently requires new and effective antibiotics. Researchers have created a promising new compound that may mark a major step forward in the global effort to ...

Chronic kidney disease (CKD) is a progressive condition in which the kidneys gradually lose their ability to filter waste ...

The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...

More than 50 million Americans suffer from chronic pain, according to the CDC. Persistent pain that lasts beyond a typical ...

The FDA has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis, a rare, progressive lung disease that can cause scarring and breathing difficulties. The approval marks the ...

More than 10 years after bringing one of the first idiopathic pulmonary fibrosis (IPF) drugs to market, Boehringer Ingelheim is freshening up its leadership in the rare lung disease space with a newly ...